457 related articles for article (PubMed ID: 18057550)
1. Involvement of ligand occupancy in Insulin-like growth factor-I (IGF-I) induced cell growth in osteoblast like MC3T3-E1 cells.
Kim SK; Kwon JY; Nam TJ
Biofactors; 2007; 29(4):187-202. PubMed ID: 18057550
[TBL] [Abstract][Full Text] [Related]
2. Insulin-like growth factor binding protein-5 (IGFBP-5) interacts with thrombospondin-1 to induce negative regulatory effects on IGF-I actions.
Moralez AM; Maile LA; Clarke J; Busby WH; Clemmons DR
J Cell Physiol; 2005 May; 203(2):328-34. PubMed ID: 15700281
[TBL] [Abstract][Full Text] [Related]
3. Blocking ligand occupancy of the alphaVbeta3 integrin inhibits insulin-like growth factor I signaling in vascular smooth muscle cells.
Zheng B; Clemmons DR
Proc Natl Acad Sci U S A; 1998 Sep; 95(19):11217-22. PubMed ID: 9736716
[TBL] [Abstract][Full Text] [Related]
4. Autocrine regulators of MC3T3-E1 cell proliferation.
Amarnani S; Merriman HL; Linkhart TA; Baylink DJ; Mohan S
J Bone Miner Res; 1993 Feb; 8(2):157-65. PubMed ID: 7680184
[TBL] [Abstract][Full Text] [Related]
5. Basic fibroblast growth factor regulates IGF-I binding proteins in the clonal osteoblastic cell line MC3T3-E1.
Hurley MM; Abreu C; Hakeda Y
J Bone Miner Res; 1995 Feb; 10(2):222-30. PubMed ID: 7538725
[TBL] [Abstract][Full Text] [Related]
6. Thrombospondin and osteopontin bind to insulin-like growth factor (IGF)-binding protein-5 leading to an alteration in IGF-I-stimulated cell growth.
Nam TJ; Busby WH; Rees C; Clemmons DR
Endocrinology; 2000 Mar; 141(3):1100-6. PubMed ID: 10698186
[TBL] [Abstract][Full Text] [Related]
7. Modulation of insulin-like growth factor actions in L6A1 myoblasts by insulin-like growth factor binding protein (IGFBP)-4 and IGFBP-5: a dual role for IGFBP-5.
Ewton DZ; Coolican SA; Mohan S; Chernausek SD; Florini JR
J Cell Physiol; 1998 Oct; 177(1):47-57. PubMed ID: 9731744
[TBL] [Abstract][Full Text] [Related]
8. Hyperglycemia alters the responsiveness of smooth muscle cells to insulin-like growth factor-I.
Maile LA; Capps BE; Ling Y; Xi G; Clemmons DR
Endocrinology; 2007 May; 148(5):2435-43. PubMed ID: 17255202
[TBL] [Abstract][Full Text] [Related]
9. Complex pattern of insulin-like growth factor binding protein expression in primary rat osteoblast enriched cultures: regulation by prostaglandin E2, growth hormone, and the insulin-like growth factors.
McCarthy TL; Casinghino S; Centrella M; Canalis E
J Cell Physiol; 1994 Jul; 160(1):163-75. PubMed ID: 7517403
[TBL] [Abstract][Full Text] [Related]
10. IGFBP-4 degradation by pregnancy-associated plasma protein-A in MC3T3 osteoblasts.
Bunn RC; Green LD; Overgaard MT; Oxvig C; Fowlkes JL
Biochem Biophys Res Commun; 2004 Dec; 325(3):698-706. PubMed ID: 15541345
[TBL] [Abstract][Full Text] [Related]
11. Fluid shear stress synergizes with insulin-like growth factor-I (IGF-I) on osteoblast proliferation through integrin-dependent activation of IGF-I mitogenic signaling pathway.
Kapur S; Mohan S; Baylink DJ; Lau KH
J Biol Chem; 2005 May; 280(20):20163-70. PubMed ID: 15778506
[TBL] [Abstract][Full Text] [Related]
12. Extracellular matrix contains insulin-like growth factor binding protein-5: potentiation of the effects of IGF-I.
Jones JI; Gockerman A; Busby WH; Camacho-Hubner C; Clemmons DR
J Cell Biol; 1993 May; 121(3):679-87. PubMed ID: 7683690
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor (IGF) binding protein-3 inhibits type 1 IGF receptor activation independently of its IGF binding affinity.
Ricort JM; Binoux M
Endocrinology; 2001 Jan; 142(1):108-13. PubMed ID: 11145572
[TBL] [Abstract][Full Text] [Related]
14. Differentiation of MC3T3-E1 osteoblasts is associated with temporal changes in the expression of IGF-I and IGFBPs.
Thrailkill KM; Siddhanti SR; Fowlkes JL; Quarles LD
Bone; 1995 Sep; 17(3):307-13. PubMed ID: 8541146
[TBL] [Abstract][Full Text] [Related]
15. Role of extracellular matrix in insulin-like growth factor (IGF) binding protein-2 regulation of IGF-II action in normal human osteoblasts.
Conover CA; Khosla S
Growth Horm IGF Res; 2003 Dec; 13(6):328-35. PubMed ID: 14624766
[TBL] [Abstract][Full Text] [Related]
16. IGF-I regulates tight-junction protein claudin-1 during differentiation of osteoblast-like MC3T3-E1 cells via a MAP-kinase pathway.
Hatakeyama N; Kojima T; Iba K; Murata M; Thi MM; Spray DC; Osanai M; Chiba H; Ishiai S; Yamashita T; Sawada N
Cell Tissue Res; 2008 Nov; 334(2):243-54. PubMed ID: 18855015
[TBL] [Abstract][Full Text] [Related]
17. Insulin-like growth factor binding protein-4 and -5 modulate ligand-dependent estrogen receptor-α activation in breast cancer cells in an IGF-independent manner.
Hermani A; Shukla A; Medunjanin S; Werner H; Mayer D
Cell Signal; 2013 Jun; 25(6):1395-402. PubMed ID: 23499909
[TBL] [Abstract][Full Text] [Related]
18. Protease-resistant form of insulin-like growth factor-binding protein 5 is an inhibitor of insulin-like growth factor-I actions on porcine smooth muscle cells in culture.
Imai Y; Busby WH; Smith CE; Clarke JB; Garmong AJ; Horwitz GD; Rees C; Clemmons DR
J Clin Invest; 1997 Nov; 100(10):2596-605. PubMed ID: 9366575
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor-I signaling in smooth muscle cells is regulated by ligand binding to the 177CYDMKTTC184 sequence of the beta3-subunit of alphaVbeta3.
Maile LA; Busby WH; Sitko K; Capps BE; Sergent T; Badley-Clarke J; Clemmons DR
Mol Endocrinol; 2006 Feb; 20(2):405-13. PubMed ID: 16195248
[TBL] [Abstract][Full Text] [Related]
20. IRS-1 Functions as a Molecular Scaffold to Coordinate IGF-I/IGFBP-2 Signaling During Osteoblast Differentiation.
Xi G; Shen X; Rosen CJ; Clemmons DR
J Bone Miner Res; 2016 Jun; 31(6):1300-14. PubMed ID: 26773517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
